DGX
Quest DiagnosticsPrevious close
251.82
Change
−1.10 / −0.43%
P/E (TTM) ?
24.5
Market Cap
$27.7B
1M
+8.04%
S&P 500 −0.91% over same period
Volume / Avg Volume
920K / 1.1M
0.87× average
Latest earnings analysisFY2026 Q3Reported 2026-10-22
Quest Diagnostics Q3 FY2026: revenue up 10.0%, adjusted EPS $3.00, guidance raised
Quest Diagnostics delivered a volume-led quarter, beat the $2.89 consensus on adjusted EPS with $3.00, and raised full-year revenue and EPS guidance — a Bullish read on the operating business. Revenue of $3.10 billion rose 10.0%, though the mix is telling: requisitions up 14.5%, revenue per requisition down 4.2%. GAAP EPS of $2.78 landed below consensus, so the quality of the beat depends on how you treat $0.24 of amortization.
Read the full analysis →Revenue$3.10BYoY +10.00%
EPS (non-GAAP)$3.00Beatest. $2.89
Next-quarter revenue guidance$12.09BAbove estimatesest. $3.04B
Next-day move+1.82%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q3 Quarter ended 2026-09 | 2026-10-22 | $3.1B | Read analysis → |
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-23 | $3.0B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-21 | $2.9B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-01-12 | $11.0B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-21 | $2.8B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-22 | $2.8B | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-23 | $2.7B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 91 of its 5-year rangeExpensive
5-year range 17.4 – 25.4 · Median 21.5
Last 4 quarters: $450M in buybacks + $369M in dividends, 2.95% of market cap combined
P/E (TTM)
24.5
P/B
3.6
P/S
2.3
Dividend Yield
2.10%
Earnings Reaction
Over the last 7 reports, the stock moved ±1.7% on average on the first trading day after, rising 3 times
Most recent +1.82%
Volatility & Correlation
1-year beta -0.10 · Correlation with S&P 500 -0.06Low beta
Annualized volatility 24% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 3 · $8.2MNet selling $8.2M
- 10-26PFEIFFER GARY MDirectorSell$0.29M1,203 shares · Avg price 243.00
- 09-01Davis J. E.CEO and PresidentSell$2.4M10,000 shares · Avg price 242.72
- 08-28PREVOZNIK MICHAEL ESVP & General CounselSell$5.5M22,677 shares · 3 trades · Avg price 243.11
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q3 | 3.10 | +10.0% | 33.6% | 0.31 | 2.78 |
| FY2026 Q2 | 3.04 | +10.2% | 33.7% | 0.32 | 2.84 |
| FY2026 Q1 | 2.90 | +9.2% | 32.5% | 0.25 | 2.24 |
| FY2025 Q4 | 2.81 | +7.1% | 32.4% | 0.25 | 2.18 |
| FY2025 Q3 | 2.82 | +13.2% | 33.7% | 0.25 | 2.16 |
| FY2025 Q2 | 2.76 | +15.2% | 34.2% | 0.28 | 2.47 |
| FY2025 Q1 | 2.65 | +12.1% | 32.5% | 0.22 | 1.94 |
| FY2024 Q4 | 2.62 | +14.6% | 32.7% | 0.22 | 1.95 |
| FY2024 Q3 | 2.49 | +8.4% | 32.6% | 0.23 | 1.99 |
| FY2024 Q2 | 2.40 | +2.5% | 33.5% | 0.23 | 2.03 |
| FY2024 Q1 | 2.37 | +1.5% | 32.6% | 0.19 | 1.72 |
| FY2023 Q4 | 2.29 | −1.9% | 32.2% | 0.19 | 1.70 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| DGX | 24.5 | +10.0% | 33.6% | +8.04% | Bullish |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |